COAGULATION FACTOR VIII INHIBITOR SCREEN PLASMA
Marquette General Health System
HLAB/HOL Code |
  | FAC8I |
MGH LIS Test No |
  | 192 |
Schedule |
  | Monday-Friday |
Testing Time |
  |   |
Testing Lab |
  | Mayo Labs |
QORR Test Code |
  | FAC8I |
Type |
  |   |
Volume |
  |   |
Temperature |
  | Frozen |
Preservative |
  |   |
Collection Info |
  | 1. Draw blood in a light blue-top (citrate) tube(s). Spin down, remove plasma, spin plasma again, and place 3 mL of platelet-poor plasma into 3 plastic vials each containing 1 mL. (Glass vial is not acceptable.) Note: 1. Specimen must be drawn prior to factor replacement therapy. 2. Double-centrifuged specimens are critical for accurate results as platelet contamination may cause spurious results. 2. Freeze specimens immediately at < or = -40 degrees C, if possible. 3. Send specimens frozen in the same shipping container. Note: Each coagulation assay requested should have its own vial. 4. If priority specimen, mark requisition, give reason, and request a call-back. |
Clinical Utilities CPT Codes Reference Range
85240/Factor VIII activity assay
85335/Factor VIII inhibitor (if appropriate)
85335/Bethesda Units (if appropriate)
80500/Interpretation (if interpretation provided by consultant)
FACTOR VIII ACTIVITY ASSAY
55-205%
Normal, full-term newborn infants or healthy premature infants
usually have normal or elevated factor VIII.*
FACTOR VIII INHIBITOR SCREEN
Negative
If positive, quantitated in Bethesda units.
BETHESDA TITER
0 Units
Component Information
Additional Comments Questions or Comments email support@mgh.org
Reference Lab Home Page
Laboratory Main Page
Marquette General Health System Home Page